Clinical Trial Update: A Phase 3 Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia [Phase 3]

View source ↗

Summary

Phase 3 trial of Pilocarpine HCl ophthalmic solution (AGN-190584) in presbyopia completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Presbyopia

Drugs mentioned

• Pilocarpine HCl ophthalmic solution (AGN-190584) (pilocarpine hydrochloride ophthalmic solution)

Snippet

Sponsor: Allergan | Conditions: Presbyopia | Phase 3 | Status: COMPLETED | Results posted: 2021-12-29